Regulation

Are We Rushing AI Into Clinics Without Proof?
Data and Information Are We Rushing AI Into Clinics Without Proof?

A quiet shift is already reshaping clinic visits as millions of people now ask chatbots for health answers before calling a nurse line, and the speed of that change keeps outpacing the slow, careful work of proving what is safe, effective, and fair. The Clinical AI Surge: Who’s Building It, Who’s Us

Is Saskatchewan Cracking Down on Unlicensed Doctors?
Care Is Saskatchewan Cracking Down on Unlicensed Doctors?

The integrity of medical services in Saskatchewan is entering a transformative phase as provincial authorities implement rigorous legislative measures to eliminate unauthorized practitioners from the healthcare system. This initiative stems from a growing demand for transparency and a

How Do REITs Affect Long-Term Care Quality and Safety?
Business How Do REITs Affect Long-Term Care Quality and Safety?

The emergence of Real Estate Investment Trusts (REITs) in the long-term care sector has fundamentally shifted how facilities operate, often placing financial performance in direct tension with patient safety. As these entities acquire thousands of buildings housing our most vulnerable citizens, the

FDA Approves Otarmeni to Treat Genetic Hearing Loss
Care FDA Approves Otarmeni to Treat Genetic Hearing Loss

A newborn infant resting in a quiet nursery currently possesses a world of silent potential that was once destined to remain forever beyond the reach of biological intervention. For decades, the standard of care for congenital deafness has been the cochlear implant, a marvel of engineering that

What Are the AHA’s Insights on the New USCDI v7 Standards?
Data and Information What Are the AHA’s Insights on the New USCDI v7 Standards?

The rapid evolution of digital health infrastructure has placed the American Hospital Association at the forefront of a critical dialogue regarding the implementation of the Office of the National Coordinator for Health Information Technology’s Draft Version 7 of the United States Core Data for I

FDA Approves Merck’s New Once-Daily HIV Treatment Idvynso
Care FDA Approves Merck’s New Once-Daily HIV Treatment Idvynso

The recent regulatory clearance of a novel therapeutic option marks a definitive departure from the historical reliance on aggressive multi-drug cocktails for the lifelong management of human immunodeficiency virus. Merck’s newly approved medication, Idvynso, represents a strategic evolution in c

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later